Graves' disease epidemiology and demographics

Jump to navigation Jump to search

Graves' disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Graves' disease from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Approach

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Hyperthyroidism
Ophtalmopathy
Dermopathy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Graves' disease epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Graves' disease epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Graves' disease epidemiology and demographics

CDC on Graves' disease epidemiology and demographics

Graves' disease epidemiology and demographics in the news

Blogs on Graves' disease epidemiology and demographics

Directions to Hospitals Treating Graves' disease

Risk calculators and risk factors for Graves' disease epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]

Overview

Graves’ disease is the most common cause of hyperthyroidism. It is estimated that it affects 20-50 cases per 100,000 persons yearly in the United States and it has a prevalence of about 0.4%.

Epidemiology and Demographics

Graves’ disease is the most common cause of hyperthyroidism.

Incidence

  • The annual incidence of Graves' disease is about 20 to 50 cases per 100,000 persons.[1]
  • Long-term variations in iodine intake do not influence the risk of the disease, but rapid iodine repletion can transiently increase the incidence.
  • The annual incidence of Graves’ disease–associated ophthalmopathy is 16 cases per 100,000 women and 3 cases per 100,000 men.

Prevalence

The prevalence of Graves’ disease in the 1970s is estimated to be 0.4% in the United States.[2] The Whickham survey in the United Kingdom suggested a prevalence of 1.1% to 1.6% for thyrotoxicosis of all causes, of which Graves’ disease was presumably the most frequent.[3]

Demographics

Age

  • The incidence peaks between 30 and 50 years of age, but people can be affected at any age.

Race

  • Graves' disease is more common in Caucasians than in Asians.[4]

Sex

  • Graves' disease is more common among women than men. The lifetime risk is 3% for women and 0.5% for men.[5]

References

  1. Zimmermann MB, Boelaert K (2015). "Iodine deficiency and thyroid disorders". Lancet Diabetes Endocrinol. 3 (4): 286–95. doi:10.1016/S2213-8587(14)70225-6. PMID 25591468.
  2. Furszyfer J, Kurland LT, McConahey WM, Woolner LB, Elveback LR (1972). "Epidemiologic aspects of Hashimoto's thyroiditis and Graves' disease in Rochester, Minnesota (1935-1967), with special reference to temporal trends". Metab. Clin. Exp. 21 (3): 197–204. PMID 5066850.
  3. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F (1995). "The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey". Clin. Endocrinol. (Oxf). 43 (1): 55–68. PMID 7641412.
  4. Tellez M, Cooper J, Edmonds C (1992). "Graves' ophthalmopathy in relation to cigarette smoking and ethnic origin". Clin. Endocrinol. (Oxf). 36 (3): 291–4. PMID 1563082.
  5. Smith TJ, Hegedüs L (2016). "Graves' Disease". N. Engl. J. Med. 375 (16): 1552–1565. doi:10.1056/NEJMra1510030. PMID 27797318.

Template:WH Template:WS